Rapid Takeaways From Late-Breaking Science at SCAI Scientific Sessions 2024 | SCAI

Interested in finding out how the late-breaking science presented at SCAI 2024 will impact your practice? Our experts distilled what you need to know: 

The CALORI Trial: Cardiac Catheterization With Liberal Oral Intake 

A liberal non-fasting strategy before cardiac catheterization significantly improves patient well-being and satisfaction without compromising safety. Few studies have prospectively explored this strategy in such a diverse patient population and with such liberal non-fasting allowances, making this the most comprehensive and generalizable study on this topic to date.  

First-in-Human Study With the Novel DurAVR Biomimetic Transcatheter Heart Valve: An Update 

The Anteris DurAVR represents new technology in the transcatheter aortic space. The DurAVR valve is on a balloon-expandable platform and utilizes a single leaflet, which is hypothesized to aid in the flow characteristics of the valve. This late-breaking study represents the first-in-human data.  

A Novel Angiographic Scoring System Predicting Side Branch Occlusion for Left Main Bifurcation PCI: The LM V-RESOLVE Score

Side branch (SB) occlusion is a risk during unprotected left main (LM) percutaneous coronary intervention (PCI). Understanding the risk factors for SB occlusion can help guide bifurcation stenting strategies and improve outcomes. This late-breaking study examined risk factors for predicting SB occlusion during LM bifurcation PCI.  

 Revascularization Strategies in Patients with Peripheral Arterial Disease Involving the Femoropopliteal Arteries: A Pooled Analysis of Individual Patient Data  

Peripheral artery disease (PAD) has a widespread impact on the general population, but women are underrepresented in peripheral vascular disease clinical trials. The optimal revascularization strategy for women with femoropopliteal disease remains unknown. This late-breaking study compares endovascular therapy of the EVT with stent implantation versus surgical bypass in patients with symptomatic PAD involving the femoropopliteal segment.  

A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF)

The ENGULF study was a multicenter first-in-human study performed to evaluate the safety and feasibility of using a new dual mechanism moderate bore Hēlo PE (pulmonary embolism) thrombectomy system. How did the device fare?

Temporal Trends and Clinical Outcomes With Radial Versus Femoral Arterial Access for Percutaneous Coronary Intervention in the U.S. 

Radial artery access for Percutaneous Coronary Intervention (PCI) is preferred over femoral artery access according to the 2021 ACC/AHA guidelines in patients with acute coronary syndrome and stable ischemic heart disease (Level of Evidence IA). As the United States has lagged behind many other countries with regard to adopting radial access as first line over the years, this study aimed to evaluate contemporary data on access site selection and associated outcomes.